Governance Classic Home
Indoco Remedies LtdPharmaceuticalsINE873D01024Consolidated₹249.01-5.43 (-2.13%)Jun-26
Valuation
Market Cap₹2.30K Cr
TTM PE778.16x
Forward PE141.48x
PEG-7.56
Book Value₹101.76
P/B2.45x
TTM EPS₹0.32
Fwd EPS₹1.76
TTM Revenue₹1.87K Cr
TTM PAT₹3.10 Cr
TTM EBITDA₹165.29 Cr
TTM EBIT₹34.01 Cr
Last Qtr PAT₹65.44 Cr
Last Qtr EBITDA₹41.02 Cr
Last Qtr EBIT₹6.49 Cr
Profitability
ROE0.33%
ROCE8.73%
TTM NPM0.17%
TTM EBITDA %8.82%
Curr OPM13.93%
Last OPM-4.98%
Curr NPM—
Last NPM—
Curr EPS₹7.09
Last EPS₹-2.57
Balance sheet
Equity₹18.46 Cr
Reserve₹920.82 Cr
Total Debt₹1,089.75 Cr
D/E1.16x
Interest %43.23%
Curr Interest₹28.29 Cr
Price / range
Close₹249.01
vs 52W High—
vs 52W Low—
MA50—
MA200—
Returns
1D-2.13%
1W-5.33%
1M+12.59%
3M+7.29%
6M+28.26%
1Y-17.55%
2Y-32.64%
3Y-30.21%
5Y-48.27%
Diwali+5.05%
Sector peers — Pharmaceuticals
CompanyCloseMkt CapTTM P/EROE
SUNPHARMA1837.30₹4.41L Cr36.4514.50%
DIVISLAB9375.00₹2.49L Cr85.0617.45%
TORNTPHARM4840.00₹1.84L Cr77.3225.70%
ZYDUSLIFE1160.00₹1.16L Cr25.8516.94%
CIPLA1394.50₹1.13L Cr33.419.75%
LAURUSLABS1954.00₹1.06L Cr96.4520.58%
AUROPHARMA1734.00₹99.77K Cr27.099.79%
DRREDDY1185.00₹98.91K Cr30.638.40%

Financial Results

Quarterly and yearly P&L · YoY % on Revenue, Total Income, Expenditure, EBITDA, EBIT, PBT, Net Profit and EPS

Standalone

16 lines · 6 periods
MetricJun-26Mar-26Dec-25Sep-25Jun-25FY25-26
Revenue408.97+4.2%449.13400.51442.12392.531,686.07
Other Income4.4710.357.176.545.5829.64
Total Income413.44+3.9%459.48407.68448.66398.111,715.71
Interest22.7522.7320.1522.0123.6188.50
Expenditure-417.56+2.1%-435.54-422.12-438.37-426.51-1,724.32
PBDT000000
EBITDA42.21+184.6%63.0325.9053.3914.83157.15
Depreciation-28.05-26.71-27.36-27.63-25.20-106.90
EBIT14.16+236.5%36.32-1.4625.76-10.3750.25
PBT93.22+428.2%27.62-20.459.76-28.40-11.47
Tax-10.90-0.270.455.290.345.81
Equity18.4618.460018.4518.46
OPM22.556.01-5.112.21-7.13-0.67
Net Profit82.32+393.4%27.35-2015.05-28.06-5.66
NPM19.915.95-4.993.40-7.05-0.33
EPS8.92+393.4%2.96-2.171.63-3.040

Yearly results

Last 6 financial years · YoY % vs previous FY

Yearly

17 lines · 6 years
MetricFY 25-26FY 24-25FY 23-24FY 22-23FY 21-22FY 20-21
Revenue1,686.07+11.1%1,518.19-15.2%1,790.81+7.4%1,666.69+8.2%1,539.72+24.1%1,240.30
Other Income29.6418.488.512.332.323.12
Total Income1,715.71+11.7%1,536.67-14.6%1,799.32+7.8%1,669.02+8.2%1,542.04+24.0%1,243.42
Expenditure-1,724.32-11.6%-1,545.03+6.8%-1,657.63-12.2%-1,477.43-13.1%-1,305.81-17.4%-1,112.07
Interest-88.50-56.63-36.82-25.03-14.14-22.22
PBDT000000
EBITDA157.15+22.7%128.04-50.4%257.98-9.4%284.89-12.9%327+46.3%223.57
Depreciation-106.90-98.25-87.98-70.60-78.95-73.12
EBIT50.25+68.7%29.79-82.5%170-20.7%214.29-13.6%248.05+64.9%150.45
PBT-11.47-55.6%-7.37-104.8%153.22-20.0%191.59-18.9%236.23+79.8%131.35
Tax5.81-1.36-36.58-50.23-81.71-38.96
Equity18.4618.450000
OPM (%)-0.67-0.489.0011.0015.0011.00
Net Profit-5.66+35.2%-8.73-107.5%116.64-17.5%141.36-8.5%154.52+67.2%92.39
NPM (%)-0.33-0.576.008.0010.007.00
EPS (Rs)00-100.0%12.66-17.5%15.34-8.5%16.77+67.2%10.03
CEPS0012.6415.3216.7710.03

Consolidated

16 lines · 6 periods
MetricJun-26Mar-26Dec-25Sep-25Jun-25FY25-26
Revenue467.50+6.8%475.61445.36484.67437.891,845.32
Other Income2.18-0.040.980.761.633.33
Total Income469.68+6.9%475.57446.34485.43439.521,848.65
Interest28.2945.9225.6424.5626.12122.25
Expenditure-489.30-2.8%-504.31-471.50-498.43-476.18-1,952.22
PBDT000000
EBITDA41.02+134.0%49.7131.5143.0517.53141.80
Depreciation-34.53-32.49-32.01-32.25-29.70-126.45
EBIT6.49+153.3%17.22-0.5010.80-12.1715.35
PBT77.72+312.0%-2500-36.66-106.51
Tax-12.281.321.864.320.317.81
Equity18.4618.460018.4518.46
OPM16.55-5.260.000.00-8.34-5.76
Net Profit65.44+280.0%-23.68-29.45-9.21-36.35-98.70
NPM13.93-4.98-6.60-1.90-8.27-5.34
EPS7.09+279.9%-2.57-3.20-1-3.940

Yearly results

Last 6 financial years · YoY % vs previous FY

Yearly

17 lines · 6 years
MetricFY 25-26FY 24-25FY 23-24FY 22-23FY 21-22FY 20-21
Revenue1,845.32+10.8%1,664.92-8.4%1,817.29+8.9%1,668.61+8.3%1,540.75+24.1%1,241.53
Other Income3.335.459.852.342.333.12
Total Income1,848.65+10.7%1,670.37-8.6%1,827.14+9.3%1,670.95+8.3%1,543.08+24.0%1,244.65
Expenditure-1,952.22-11.8%-1,745.73-2.5%-1,702.87-15.2%-1,478.15-13.1%-1,306.51-17.4%-1,112.65
Interest-122.25-66.23-38.02-25.03-14.14-22.26
PBDT000000
EBITDA141.80+42.9%99.26-59.4%244.31-14.6%286.10-12.6%327.34+46.0%224.27
Depreciation-126.45-113.84-91.87-70.61-78.96-73.13
EBIT15.35+205.3%-14.58-109.6%152.44-29.3%215.49-13.2%248.38+64.3%151.14
PBT-106.51-43.2%-74.37-154.8%135.80-29.6%192.80-18.5%236.57+79.2%132
Tax7.81-3.58-38.79-50.55-81.77-38.95
Equity18.4618.450000
OPM (%)-5.76-4.457.4311.5415.3310.61
Net Profit-98.70-26.6%-77.95-180.4%97.01-31.8%142.25-8.1%154.80+66.4%93.05
NPM (%)-5.34-4.675.318.5110.037.48
EPS (Rs)0-100.0%8.46-19.7%10.53-31.8%15.44-8.1%16.80+66.3%10.10
CEPS08.4510.5115.4216.8010.10

Corporate Actions

Dividends, bonus issues, and stock splits

Dividend

21
YearTypeAmountEx-Date
2025Final Dividend0.204 Sep 2025
2024Final Dividend1.519 Sep 2024
2023Final Dividend2.2518 Sep 2023
2022Final Dividend1.514 Sep 2022
2022Special Dividend0.7514 Sep 2022
2021Final Dividend1.517 Sep 2021
2020Final Dividend0.318 Sep 2020
2019Final Dividend0.322 Aug 2019
2018Final Dividend131 Aug 2018
2017Final Dividend1.631 Jul 2017
2016Final Dividend0.220 Jul 2016
2016Interim Dividend1.417 Mar 2016
2015Final Dividend1.621 Jul 2015
2014Final Dividend1.421 Jul 2014
2013Final Dividend1.119 Jul 2013
2012Final Dividend1.120 Jul 2012
2011Final Dividend819 Jul 2011
2010Final Dividend713 Jul 2010
2009Final Dividend209 Sep 2009
2009Interim Dividend3.2511 Dec 2008
2008Final Dividend519 Sep 2008

Bonus

1
YearRatioEx-Date
20121:217 May 2012

Split

1
YearRatioEx-Date
2012Rs.10/- to Rs.2/-17 May 2012
Loading company dashboard...
Fetching ratios, charts, and peers